Determination of alendronate in low volumes of plasma by column-switching high-performance liquid chromatography method and its application to pharmacokinetic studies in human plasma

Archives of Pharmacal Research

Volumn 34, Issue 12, 2011, Pages 2079-2086

  Ban, Eunmi ^a,b   Park, Ji Youn ^b   Kim, Hyung Tae ^c   Kim, Chong Kook ^a,d  

^a Seoul National University   (South Korea)

^b Bio Medieng Ltd   (South Korea)

^c Sungkyunkwan University   (South Korea)

^d Inje University   (South Korea)

Author keywords

Alendronate; Column switching; High performance liquid chromatography (HPLC); Pharmacokinetic study

Indexed keywords

9 FLUORENYLMETHYL CHLOROFORMATE; ALENDRONIC ACID; CALCIUM CHLORIDE; CITRATE SODIUM; CITRIC ACID; EDETATE CALCIUM DISODIUM; PAMIDRONIC ACID; SODIUM HYDROXIDE;

ACCURACY; AREA UNDER THE CURVE; ARTICLE; DRUG BLOOD LEVEL; DRUG HALF LIFE; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; MAXIMUM PLASMA CONCENTRATION; NORMAL HUMAN; SINGLE DRUG DOSE;

ALENDRONATE; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; REPRODUCIBILITY OF RESULTS;

EID: 84863173093     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-011-1211-z     Document Type: Article

References (21)

1. Al Deeb, S. K., Hamdan, I. I., and Al Najjar, S. M., Spectroscopic and HPLC methods for the determination of alendronate in tablets and urine. Talanta, 64, 695-702 (2004).
2. Hosking, D., Chilvers, C. E., Christiansen, C., Ravn, P., Wasnich, R., Ross, P., McClung, M., Balske, A., Thompson, D., Daley, M., and Yates, A. J., Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group. N. Engl. J. Med., 338, 485-492 (1998). (Pubitemid 28103131)
3. Hyldstrup, L., Flesch, G., and Hauffe, S. A., Pharmacokinetic evaluation of pamidronate after oral administration: a study on dose proportionality, absolute bioavailability, and effect of repeated administration. Calcif. Tissue Int., 53, 297-300 (1993). (Pubitemid 23298409)
4. Kang, H. S., Hwang, S. J., Kim, C. K., and Park, J. S., HPLC method validation and pharmacokinetic study of alendronate sodium in human urine with fluorescence detection. J. Liq. Chromatogr. Relat. Technol., 29, 1589-1600 (2006).
5. Lin, J. H., Duggan, D. E., Chen, I. W., and Ellsworth, R. L., Physiological disposition of alendronate, a potent antiosteolytic bisphosphonate, in laboratory animals. Drug Metab. Dispos., 19, 926-932 (1991).
6. Lin, J. H., Chen, I. W., and Duggan, D. E., Effects of dose, sex, and age on the disposition of alendronate, a potent antiosteolytic bisphosphonate, in rats. Drug Metab. Dispos., 20, 473-478 (1992a).
7. Lin, J. H., Chen, I. W., Deluna, F. A., and Hichens, M., Renal handling of alendronate in rats. An uncharacterized renal transport system. Drug Metab. Dispos., 20, 608-613 (1992b).
8. Mönkkönen, H., Moilanen, P., Mönkkönen, J., Frith, J. C., Rogers, M. J., and Auriola, S., Analysis of an adenine nucleotide- containing metabolite of clodronate using ion pair high-performance liquid chromatography-electrospray ionisation mass spectrometry. J. Chromatogr. B Biomed. Sci. Appl., 738, 395-403 (2000). (Pubitemid 30089465)
9. Niemi, R., Taipale, H., Ahlmark, M., Vepsäläinen, J., and Järvinen, T., Simultaneous determination of clodronate and its partial ester derivatives by ion-pair reversed-phase high-performance liquid chromatography coupled with evaporative light-scattering detection. J. Chromatogr. B Biomed. Sci. Appl., 701, 97-102 (1997). (Pubitemid 27473964)
10. Ptáček, P., Klíma, J., and Macek, J., Determination of alendronate in human urine as 9-fluorenylmethyl derivative by high-performance liquid chromatography. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 767, 111-116 (2002). (Pubitemid 34142342)
11. Russell, R. G. and Rogers, M. J., Bisphosphonates: from the laboratory to the clinic and back again. Bone, 25, 97-106 (1999). (Pubitemid 29322070)
12. Sparidans, R. W. and den Hartigh, J., Chromatographic analysis of bisphosphonates. Pharm. World Sci., 21, 1-10 (1999). (Pubitemid 29161692)
13. Tarcomnicu, I., Silvestro, L., Savu, S. R., Gherase, A., and Dulea, C., Development and application of a high-performance liquid chromatography-mass spectrometry method to determine alendronate in human urine. J. Chromatogr. A, 1160, 21-33 (2007). (Pubitemid 47068467)
14. Tsai, E. W., Singh, M. M., Lu, H. H., Ip, D. P., and Brooks, M. A., Application of capillary electrophoresis to pharmaceutical analysis: Determination of alendronate in dosage forms. J. Chromatogr. A, 626, 245-250 (1992). (Pubitemid 23014888)
15. Usui, T., Watanabe, T., and Higuchi, S., Determination of a new bisphosphonate, YM175, in plasma, urine and bone by high-performance liquid chromatography with electrochemical detection. J. Chromatogr., 584, 213-220 (1992).
16. Usui, T., Kawakami, R., Watanabe, T., and Higuchi, S., Sensitive determination of a novel bisphosphonate, YM529, in plasma, urine and bone by high-performance liquid chromatography with fluorescence detection. J. Chromatogr., 652, 67-72 (1994). (Pubitemid 24079350)
17. Wong, J. A., Renton, K. W., Crocker, J. F., O'Regan, P. A., and Acott, P. D., Determination of pamidronate in human whole blood and urine by reversed-phase HPLC with fluorescence detection. Biomed. Chromatogr., 18, 98-101 (2004). (Pubitemid 38444495)
18. Yakatan, G. J., Poynor, W. J., Talbert, R. L., Floyd, B. F., Slough, C. L., Ampulski, R. S., and Benedict, J. J., Clodronate kinetics and bioavailability. Clin. Pharmacol. Ther., 31, 402-410 (1982). (Pubitemid 12125462)
19. Yun, M. H. and Kwon, K. I., High-performance liquid chromatography method for determining alendronate sodium in human plasma by detecting fluorescence: application to a pharmacokinetic study in humans. J. Pharm. Biomed. Anal., 40, 168-172 (2006).
20. Zacharis, C. K. and Tzanavaras, P. D., Determination of bisphosphonate active pharmaceutical ingredients in pharmaceuticals and biological material: a review of analytical methods. J. Pharm. Biomed. Anal., 48, 483-496 (2008).
21. Zhu, L. S., Lapko, V. N., Lee, J. W., Basir, Y. J., Kafonek, C., Olsen, R., and Briscoe, C., A general approach for the quantitative analysis of bisphosphonates in human serum and urine by high-performance liquid chromatography/ tandem mass spectrometry. Rapid Commun. Mass Spectrom., 20, 3421-3426 (2006). (Pubitemid 44763942)